Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-20-054727

Chief Medical Officer sold 52,906 shares at an average $40.74 ($2,155,603)

  • Chief Medical Officer acquired 52,906 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2020-10-08 Option exercise +22,906 $5.28 $120,944 189,523 I
Ho Carole Chief Medical Officer 2020-10-08 Sale −22,906 $40.12 $918,989 166,617 I
Ho Carole Chief Medical Officer 2020-10-09 Option exercise +30,000 $5.28 $158,400 196,617 I
Ho Carole Chief Medical Officer 2020-10-09 Sale −10,465 $40.68 $425,716 186,152 I
Ho Carole Chief Medical Officer 2020-10-09 Sale −19,535 $41.51 $810,898 166,617 I
Derivatives
Ho Carole Chief Medical Officer 2020-10-08 Option exercise · Stock Option (right to buy) −13,020 44,035 D
Ho Carole Chief Medical Officer 2020-10-08 Option exercise · Stock Option (right to buy) −9,886 68,240 D
Ho Carole Chief Medical Officer 2020-10-09 Option exercise · Stock Option (right to buy) −30,000 38,240 D
Open-market sales · 52,906 sh · avg $40.74 · $2,155,603
Loading xslF345X03/doc4.xml…